0000000000591784

AUTHOR

Tilmann Grus

0000-0001-8316-0832

showing 7 related works from this author

Squaric Acid-Based Radiopharmaceuticals for Tumor Imaging and Therapy.

2021

Targeting vectors bound to a chelator represent a significant fraction of radiopharmaceuticals used nowadays for diagnostic and therapeutic purposes in nuclear medicine. The use of squaramides as coupling units for chelator and targeting vector helps to circumvent the disadvantages of several common coupling methods. This review gives an overview of the use of squaric acid diesters (SADE) as linking agents. It focuses on the conjugation of cyclic chelators, e.g., DOTA (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid), as well as hybrid chelators like AAZTA5 (6-pentanoic acid-6-amino-1,4-diazepine tetracetic acid) or DATA5m (6-pentanoic acid-6-amino-1,4-diazapine-triacetate) to diff…

medicine.drug_classBiomedical EngineeringPharmaceutical ScienceBioengineering02 engineering and technologySquaric acidMonoclonal antibody01 natural scienceschemistry.chemical_compoundFibroblast activation protein alphaIn vivoNeoplasmsmedicineDOTAHumansChelationPharmacology010405 organic chemistryChemistryOrganic Chemistry021001 nanoscience & nanotechnologyCombinatorial chemistrySmall molecule0104 chemical sciencesPositron-Emission TomographyRadiopharmaceuticals0210 nano-technologyCyclobutanesBiotechnologyConjugateBioconjugate chemistry
researchProduct

Hybrid Chelator-Based PSMA Radiopharmaceuticals: Translational Approach

2021

(1) Background: Prostate-specific membrane antigen (PSMA) has been extensively studied in the last decade. It became a promising biological target in the diagnosis and therapy of PSMA-expressing cancer diseases. Although there are several radiolabeled PSMA inhibitors available, the search for new compounds with improved pharmacokinetic properties and simplified synthesis is still ongoing. In this study, we developed PSMA ligands with two different hybrid chelators and a modified linker. Both compounds have displayed a promising pharmacokinetic profile. (2) Methods: DATA5m.SA.KuE and AAZTA5.SA.KuE were synthesized. DATA5m.SA.KuE was labeled with gallium-68 and radiochemical yields of various…

Diagnostic ImagingGlutamate Carboxypeptidase IIBiodistributionmedia_common.quotation_subjectPharmaceutical ScienceOrganic chemistryChemistry Techniques Syntheticurologic and male genital diseasesArticleAnalytical ChemistryTranslational Research BiomedicalMicechemistry.chemical_compoundhybrid chelatorNude mouseQD241-441In vivoNeoplasmsDrug DiscoveryLNCaPAnimalsHumansChelationradionuclide diagnosis and therapyPhysical and Theoretical ChemistryInternalizationChelating Agentsmedia_commonMolecular StructurebiologyChemistryRadiochemistrybiology.organism_classificationDisease Models AnimalKineticsChemistry (miscellaneous)Isotope LabelingAntigens SurfaceHeterograftsMolecular MedicineRadiopharmaceuticalsAmmonium acetateEx vivoprostate specific membrane antigen PSMAProtein BindingMolecules
researchProduct

AAZTA5.SA.KuE, a versatile tool for theranostic application – labeling, in vitro, and first in vivo-investigation of [ 177 Lu]Lu- AAZTA 5 .SA.KuE

2020

BiochemistryChemistryIn vivoIn vitro58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin
researchProduct

[68Ga]Ga-THP-Pam: A Bisphosphonate PET Tracer with Facile Radiolabeling and Broad Calcium Mineral Affinity

2020

Calcium minerals such as hydroxyapatite (HAp) can be detected non-invasively in vivo using nuclear imaging agents such as [18F]NaF (available from cyclotrons), for positron emission tomography (PET) and 99mTc-radiolabelled bisphosphonates (BP; available from 99mTc generators for single photon emission computed tomography (SPECT) or scintigraphy). These two types of imaging agents allow detection of bone metastases (based on the presence of HAp) and vascular calcification lesions (that contain HAp and other calcium minerals). With the aim of developing a cyclotron-independent PET radiotracer for these lesions, with broad calcium mineral affinity and simple one-step radiolabelling, we develop…

BiodistributionBiomedical EngineeringPharmaceutical Sciencechemistry.chemical_elementBioengineering02 engineering and technologyCalciumScintigraphyBone tissue01 natural sciencesIn vivomedicineChelationPharmacologymedicine.diagnostic_test010405 organic chemistryOrganic ChemistryRadiochemistry021001 nanoscience & nanotechnologyIn vitro0104 chemical sciencesmedicine.anatomical_structurechemistryPositron emission tomography0210 nano-technologyBiotechnologyBioconjugate Chemistry
researchProduct

Dinitrophenol-beinhaltende Glutamat-Urea-basierte PSMA-Liganden zur Diagnose und Therapie von Prostatakarzinomen

2020

58. Jahrestagung der Deutschen Gesellschaft für Nuklearmedizin
researchProduct

Mild and efficient 64Cu labeling of perhydro-1, 4-diazepine derivatives for potential use with large peptides, proteins and antibodies

2020

Abstract DATA (6-Amino-1,4-diazapine-triacetate) and AAZTA (6-Amino-1,4-diazapine-tetracetate) chelators represent a novel approach representing hybrid-chelates: possessing significant cyclic and acyclic character. It is believed that flexibility of the acyclic part facilitates rapid complexation, whilst the preorganized cyclic part minimizes the energy barrier to complexation and inhibits decomplexation processes. So far, these chelators have been used exclusively with 44Sc and 68Ga only. Recent results with natCu predict high stabilities for Cu-AAZTA, yet no radioactive labeling of AAZTA or DATA with 64Cu or any additional radioactive isotope has been reported. We present the one pot synt…

chemistry.chemical_compoundDiazepinechemistrybiology010405 organic chemistrybiology.proteinPhysical and Theoretical ChemistryAntibody010402 general chemistry01 natural sciencesCombinatorial chemistry0104 chemical sciencesRadiochimica Acta
researchProduct

Synthesis and labeling of a squaric acid containing PSMA-inhibitor coupled to AAZTA5 for versatile labeling with 44Sc, 64Cu, 68Ga and 177Lu

2020

chemistry.chemical_compoundRadiationchemistrySquaric acidCombinatorial chemistryApplied Radiation and Isotopes
researchProduct